# Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)

> **NCT02794155** · PHASE2 · COMPLETED · sponsor: **Diasome Pharmaceuticals** · enrollment: 157 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** HDV Insulin Lispro
- **DRUG:** Insulin LISPRO

## Key facts

- **NCT ID:** NCT02794155
- **Lead sponsor:** Diasome Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-04-28
- **Final completion:** 2018-06-15
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2018-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02794155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02794155, "Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02794155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*